Online Program

Using the international classification of functioning, disability and health as a framework for determining paralysis prevalence in the u.s

Monday, November 4, 2013 : 10:30 a.m. - 10:45 a.m.

Michael Fox, PhD, Centers for Disease Control and Prevention, Atlanta, GA
Gloria L. Krahn, PhD, MPH, Division of Human Development and Disability, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA
Anthony Cahill, PhD, University of New Mexico, Center for Development and Disability, Albuquerque, NM
Accurately estimating the prevalence of disabling conditions is a necessary but frequently overlooked step in developing sound, appropriate and effective policies, programs and services targeted at subpopulations. Over the last several decades, various methods have been used to estimate the prevalence of paralysis including registries, hospital discharge datasets, data from suppliers of durable medical equipment and population-based surveys. Estimates from each of these data sources have frequently resulted in widely divergent results. This paper addresses two issues. First, what accounts for the differences in estimates resulting from these various methods? Second, what are the relative strengths and weaknesses of estimation methods that have been used to estimate the prevalence of paralysis? These issues are discussed within the context of a multi-year effort to address shortcomings in historical estimates of paralysis involving researchers from universities across the country and federal agencies.

Learning Areas:


Learning Objectives:
Assess alternative approaches to estimating prevalence of paralysis differentiate strengths and weaknesses of approaches to estimation

Keyword(s): Disability

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: In both the academic and government fields, I have over twenty years of experience in analyzing disability-related data.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.